 | • レポートコード：QFJ1-4570 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、神経調節物質注射の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ボツリヌス毒素、ヒアルロン酸、ヒドロキシアパタイトカルシウム、ポリ-L-乳酸、その他）、用途別市場規模（病院、皮膚科クリニック、スパ、エステティッククリニック）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・神経調節物質注射の市場動向 ・企業の競争状況、市場シェア ・神経調節物質注射の種類別市場規模と予測2016-2027（ボツリヌス毒素、ヒアルロン酸、ヒドロキシアパタイトカルシウム、ポリ-L-乳酸、その他） ・神経調節物質注射の用途別市場規模と予測2016-2027（病院、皮膚科クリニック、スパ、エステティッククリニック） ・神経調節物質注射の北米市場規模2016-2027（アメリカ、カナダ） ・神経調節物質注射の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・神経調節物質注射のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・神経調節物質注射の中南米市場規模2016-2027（メキシコ、ブラジル） ・神経調節物質注射の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（ALLERGAN、Merz Pharma、Suneva Medical、Medytox、Sinclair Pharma、Bloomage BioTechnology Corporation Limited、Anika Therapeutics、Galderma、Bausch Health Companies、Integra Lifesciences） ・結論 |
Market Analysis and Insights: Global Neuromodulators Injectable Market
The global Neuromodulators Injectable market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Neuromodulators Injectable market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Neuromodulators Injectable market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Neuromodulators Injectable market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Neuromodulators Injectable market.
Global Neuromodulators Injectable Scope and Market Size
Neuromodulators Injectable market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Neuromodulators Injectable market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Botulinum Toxin
Hyaluronic Acid
Calcium Hydroxylapatite
Poly-l-Lactic Acid
Others
Segment by Application
Hospitals
Dermatology Clinics
Spas and Aesthetic Clinics
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
ALLERGAN
Merz Pharma
Suneva Medical
Medytox
Sinclair Pharma
Bloomage BioTechnology Corporation Limited
Anika Therapeutics
Galderma
Bausch Health Companies
Integra Lifesciences
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Neuromodulators Injectable Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Botulinum Toxin
1.2.3 Hyaluronic Acid
1.2.4 Calcium Hydroxylapatite
1.2.5 Poly-l-Lactic Acid
1.2.6 Others
1.3 Market by Application
1.3.1 Global Neuromodulators Injectable Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Dermatology Clinics
1.3.4 Spas and Aesthetic Clinics
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Neuromodulators Injectable Market Perspective (2016-2027)
2.2 Neuromodulators Injectable Growth Trends by Regions
2.2.1 Neuromodulators Injectable Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Neuromodulators Injectable Historic Market Share by Regions (2016-2021)
2.2.3 Neuromodulators Injectable Forecasted Market Size by Regions (2022-2027)
2.3 Neuromodulators Injectable Industry Dynamic
2.3.1 Neuromodulators Injectable Market Trends
2.3.2 Neuromodulators Injectable Market Drivers
2.3.3 Neuromodulators Injectable Market Challenges
2.3.4 Neuromodulators Injectable Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Neuromodulators Injectable Players by Revenue
3.1.1 Global Top Neuromodulators Injectable Players by Revenue (2016-2021)
3.1.2 Global Neuromodulators Injectable Revenue Market Share by Players (2016-2021)
3.2 Global Neuromodulators Injectable Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Neuromodulators Injectable Revenue
3.4 Global Neuromodulators Injectable Market Concentration Ratio
3.4.1 Global Neuromodulators Injectable Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Neuromodulators Injectable Revenue in 2020
3.5 Neuromodulators Injectable Key Players Head office and Area Served
3.6 Key Players Neuromodulators Injectable Product Solution and Service
3.7 Date of Enter into Neuromodulators Injectable Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Neuromodulators Injectable Breakdown Data by Type
4.1 Global Neuromodulators Injectable Historic Market Size by Type (2016-2021)
4.2 Global Neuromodulators Injectable Forecasted Market Size by Type (2022-2027)
5 Neuromodulators Injectable Breakdown Data by Application
5.1 Global Neuromodulators Injectable Historic Market Size by Application (2016-2021)
5.2 Global Neuromodulators Injectable Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Neuromodulators Injectable Market Size (2016-2027)
6.2 North America Neuromodulators Injectable Market Size by Type
6.2.1 North America Neuromodulators Injectable Market Size by Type (2016-2021)
6.2.2 North America Neuromodulators Injectable Market Size by Type (2022-2027)
6.2.3 North America Neuromodulators Injectable Market Size by Type (2016-2027)
6.3 North America Neuromodulators Injectable Market Size by Application
6.3.1 North America Neuromodulators Injectable Market Size by Application (2016-2021)
6.3.2 North America Neuromodulators Injectable Market Size by Application (2022-2027)
6.3.3 North America Neuromodulators Injectable Market Size by Application (2016-2027)
6.4 North America Neuromodulators Injectable Market Size by Country
6.4.1 North America Neuromodulators Injectable Market Size by Country (2016-2021)
6.4.2 North America Neuromodulators Injectable Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Neuromodulators Injectable Market Size (2016-2027)
7.2 Europe Neuromodulators Injectable Market Size by Type
7.2.1 Europe Neuromodulators Injectable Market Size by Type (2016-2021)
7.2.2 Europe Neuromodulators Injectable Market Size by Type (2022-2027)
7.2.3 Europe Neuromodulators Injectable Market Size by Type (2016-2027)
7.3 Europe Neuromodulators Injectable Market Size by Application
7.3.1 Europe Neuromodulators Injectable Market Size by Application (2016-2021)
7.3.2 Europe Neuromodulators Injectable Market Size by Application (2022-2027)
7.3.3 Europe Neuromodulators Injectable Market Size by Application (2016-2027)
7.4 Europe Neuromodulators Injectable Market Size by Country
7.4.1 Europe Neuromodulators Injectable Market Size by Country (2016-2021)
7.4.2 Europe Neuromodulators Injectable Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Neuromodulators Injectable Market Size (2016-2027)
8.2 Asia-Pacific Neuromodulators Injectable Market Size by Type
8.2.1 Asia-Pacific Neuromodulators Injectable Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Neuromodulators Injectable Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Neuromodulators Injectable Market Size by Type (2016-2027)
8.3 Asia-Pacific Neuromodulators Injectable Market Size by Application
8.3.1 Asia-Pacific Neuromodulators Injectable Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Neuromodulators Injectable Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Neuromodulators Injectable Market Size by Application (2016-2027)
8.4 Asia-Pacific Neuromodulators Injectable Market Size by Region
8.4.1 Asia-Pacific Neuromodulators Injectable Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Neuromodulators Injectable Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Neuromodulators Injectable Market Size (2016-2027)
9.2 Latin America Neuromodulators Injectable Market Size by Type
9.2.1 Latin America Neuromodulators Injectable Market Size by Type (2016-2021)
9.2.2 Latin America Neuromodulators Injectable Market Size by Type (2022-2027)
9.2.3 Latin America Neuromodulators Injectable Market Size by Type (2016-2027)
9.3 Latin America Neuromodulators Injectable Market Size by Application
9.3.1 Latin America Neuromodulators Injectable Market Size by Application (2016-2021)
9.3.2 Latin America Neuromodulators Injectable Market Size by Application (2022-2027)
9.3.3 Latin America Neuromodulators Injectable Market Size by Application (2016-2027)
9.4 Latin America Neuromodulators Injectable Market Size by Country
9.4.1 Latin America Neuromodulators Injectable Market Size by Country (2016-2021)
9.4.2 Latin America Neuromodulators Injectable Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Neuromodulators Injectable Market Size (2016-2027)
10.2 Middle East & Africa Neuromodulators Injectable Market Size by Type
10.2.1 Middle East & Africa Neuromodulators Injectable Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Neuromodulators Injectable Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Neuromodulators Injectable Market Size by Type (2016-2027)
10.3 Middle East & Africa Neuromodulators Injectable Market Size by Application
10.3.1 Middle East & Africa Neuromodulators Injectable Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Neuromodulators Injectable Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Neuromodulators Injectable Market Size by Application (2016-2027)
10.4 Middle East & Africa Neuromodulators Injectable Market Size by Country
10.4.1 Middle East & Africa Neuromodulators Injectable Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Neuromodulators Injectable Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 ALLERGAN
11.1.1 ALLERGAN Company Details
11.1.2 ALLERGAN Business Overview
11.1.3 ALLERGAN Neuromodulators Injectable Introduction
11.1.4 ALLERGAN Revenue in Neuromodulators Injectable Business (2016-2021)
11.1.5 ALLERGAN Recent Development
11.2 Merz Pharma
11.2.1 Merz Pharma Company Details
11.2.2 Merz Pharma Business Overview
11.2.3 Merz Pharma Neuromodulators Injectable Introduction
11.2.4 Merz Pharma Revenue in Neuromodulators Injectable Business (2016-2021)
11.2.5 Merz Pharma Recent Development
11.3 Suneva Medical
11.3.1 Suneva Medical Company Details
11.3.2 Suneva Medical Business Overview
11.3.3 Suneva Medical Neuromodulators Injectable Introduction
11.3.4 Suneva Medical Revenue in Neuromodulators Injectable Business (2016-2021)
11.3.5 Suneva Medical Recent Development
11.4 Medytox
11.4.1 Medytox Company Details
11.4.2 Medytox Business Overview
11.4.3 Medytox Neuromodulators Injectable Introduction
11.4.4 Medytox Revenue in Neuromodulators Injectable Business (2016-2021)
11.4.5 Medytox Recent Development
11.5 Sinclair Pharma
11.5.1 Sinclair Pharma Company Details
11.5.2 Sinclair Pharma Business Overview
11.5.3 Sinclair Pharma Neuromodulators Injectable Introduction
11.5.4 Sinclair Pharma Revenue in Neuromodulators Injectable Business (2016-2021)
11.5.5 Sinclair Pharma Recent Development
11.6 Bloomage BioTechnology Corporation Limited
11.6.1 Bloomage BioTechnology Corporation Limited Company Details
11.6.2 Bloomage BioTechnology Corporation Limited Business Overview
11.6.3 Bloomage BioTechnology Corporation Limited Neuromodulators Injectable Introduction
11.6.4 Bloomage BioTechnology Corporation Limited Revenue in Neuromodulators Injectable Business (2016-2021)
11.6.5 Bloomage BioTechnology Corporation Limited Recent Development
11.7 Anika Therapeutics
11.7.1 Anika Therapeutics Company Details
11.7.2 Anika Therapeutics Business Overview
11.7.3 Anika Therapeutics Neuromodulators Injectable Introduction
11.7.4 Anika Therapeutics Revenue in Neuromodulators Injectable Business (2016-2021)
11.7.5 Anika Therapeutics Recent Development
11.8 Galderma
11.8.1 Galderma Company Details
11.8.2 Galderma Business Overview
11.8.3 Galderma Neuromodulators Injectable Introduction
11.8.4 Galderma Revenue in Neuromodulators Injectable Business (2016-2021)
11.8.5 Galderma Recent Development
11.9 Bausch Health Companies
11.9.1 Bausch Health Companies Company Details
11.9.2 Bausch Health Companies Business Overview
11.9.3 Bausch Health Companies Neuromodulators Injectable Introduction
11.9.4 Bausch Health Companies Revenue in Neuromodulators Injectable Business (2016-2021)
11.9.5 Bausch Health Companies Recent Development
11.10 Integra Lifesciences
11.10.1 Integra Lifesciences Company Details
11.10.2 Integra Lifesciences Business Overview
11.10.3 Integra Lifesciences Neuromodulators Injectable Introduction
11.10.4 Integra Lifesciences Revenue in Neuromodulators Injectable Business (2016-2021)
11.10.5 Integra Lifesciences Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Neuromodulators Injectable Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Botulinum Toxin
Table 3. Key Players of Hyaluronic Acid
Table 4. Key Players of Calcium Hydroxylapatite
Table 5. Key Players of Poly-l-Lactic Acid
Table 6. Key Players of Others
Table 7. Global Neuromodulators Injectable Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Neuromodulators Injectable Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Neuromodulators Injectable Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Neuromodulators Injectable Market Share by Regions (2016-2021)
Table 11. Global Neuromodulators Injectable Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Neuromodulators Injectable Market Share by Regions (2022-2027)
Table 13. Neuromodulators Injectable Market Trends
Table 14. Neuromodulators Injectable Market Drivers
Table 15. Neuromodulators Injectable Market Challenges
Table 16. Neuromodulators Injectable Market Restraints
Table 17. Global Neuromodulators Injectable Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Neuromodulators Injectable Market Share by Players (2016-2021)
Table 19. Global Top Neuromodulators Injectable Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neuromodulators Injectable as of 2020)
Table 20. Ranking of Global Top Neuromodulators Injectable Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Neuromodulators Injectable Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Neuromodulators Injectable Product Solution and Service
Table 24. Date of Enter into Neuromodulators Injectable Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Neuromodulators Injectable Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Neuromodulators Injectable Revenue Market Share by Type (2016-2021)
Table 28. Global Neuromodulators Injectable Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Neuromodulators Injectable Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Neuromodulators Injectable Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Neuromodulators Injectable Revenue Market Share by Application (2016-2021)
Table 32. Global Neuromodulators Injectable Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Neuromodulators Injectable Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Neuromodulators Injectable Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Neuromodulators Injectable Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Neuromodulators Injectable Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Neuromodulators Injectable Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Neuromodulators Injectable Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Neuromodulators Injectable Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Neuromodulators Injectable Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Neuromodulators Injectable Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Neuromodulators Injectable Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Neuromodulators Injectable Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Neuromodulators Injectable Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Neuromodulators Injectable Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Neuromodulators Injectable Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Neuromodulators Injectable Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Neuromodulators Injectable Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Neuromodulators Injectable Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Neuromodulators Injectable Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Neuromodulators Injectable Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Neuromodulators Injectable Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Neuromodulators Injectable Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Neuromodulators Injectable Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Neuromodulators Injectable Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Neuromodulators Injectable Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Neuromodulators Injectable Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Neuromodulators Injectable Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Neuromodulators Injectable Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Neuromodulators Injectable Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Neuromodulators Injectable Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Neuromodulators Injectable Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Neuromodulators Injectable Market Size by Country (2022-2027) & (US$ Million)
Table 64. ALLERGAN Company Details
Table 65. ALLERGAN Business Overview
Table 66. ALLERGAN Neuromodulators Injectable Product
Table 67. ALLERGAN Revenue in Neuromodulators Injectable Business (2016-2021) & (US$ Million)
Table 68. ALLERGAN Recent Development
Table 69. Merz Pharma Company Details
Table 70. Merz Pharma Business Overview
Table 71. Merz Pharma Neuromodulators Injectable Product
Table 72. Merz Pharma Revenue in Neuromodulators Injectable Business (2016-2021) & (US$ Million)
Table 73. Merz Pharma Recent Development
Table 74. Suneva Medical Company Details
Table 75. Suneva Medical Business Overview
Table 76. Suneva Medical Neuromodulators Injectable Product
Table 77. Suneva Medical Revenue in Neuromodulators Injectable Business (2016-2021) & (US$ Million)
Table 78. Suneva Medical Recent Development
Table 79. Medytox Company Details
Table 80. Medytox Business Overview
Table 81. Medytox Neuromodulators Injectable Product
Table 82. Medytox Revenue in Neuromodulators Injectable Business (2016-2021) & (US$ Million)
Table 83. Medytox Recent Development
Table 84. Sinclair Pharma Company Details
Table 85. Sinclair Pharma Business Overview
Table 86. Sinclair Pharma Neuromodulators Injectable Product
Table 87. Sinclair Pharma Revenue in Neuromodulators Injectable Business (2016-2021) & (US$ Million)
Table 88. Sinclair Pharma Recent Development
Table 89. Bloomage BioTechnology Corporation Limited Company Details
Table 90. Bloomage BioTechnology Corporation Limited Business Overview
Table 91. Bloomage BioTechnology Corporation Limited Neuromodulators Injectable Product
Table 92. Bloomage BioTechnology Corporation Limited Revenue in Neuromodulators Injectable Business (2016-2021) & (US$ Million)
Table 93. Bloomage BioTechnology Corporation Limited Recent Development
Table 94. Anika Therapeutics Company Details
Table 95. Anika Therapeutics Business Overview
Table 96. Anika Therapeutics Neuromodulators Injectable Product
Table 97. Anika Therapeutics Revenue in Neuromodulators Injectable Business (2016-2021) & (US$ Million)
Table 98. Anika Therapeutics Recent Development
Table 99. Galderma Company Details
Table 100. Galderma Business Overview
Table 101. Galderma Revenue in Neuromodulators Injectable Business (2016-2021) & (US$ Million)
Table 102. Galderma Recent Development
Table 103. Bausch Health Companies Company Details
Table 104. Bausch Health Companies Business Overview
Table 105. Bausch Health Companies Neuromodulators Injectable Product
Table 106. Bausch Health Companies Revenue in Neuromodulators Injectable Business (2016-2021) & (US$ Million)
Table 107. Bausch Health Companies Recent Development
Table 108. Integra Lifesciences Company Details
Table 109. Integra Lifesciences Business Overview
Table 110. Integra Lifesciences Neuromodulators Injectable Product
Table 111. Integra Lifesciences Revenue in Neuromodulators Injectable Business (2016-2021) & (US$ Million)
Table 112. Integra Lifesciences Recent Development
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Neuromodulators Injectable Market Share by Type: 2020 VS 2027
Figure 2. Botulinum Toxin Features
Figure 3. Hyaluronic Acid Features
Figure 4. Calcium Hydroxylapatite Features
Figure 5. Poly-l-Lactic Acid Features
Figure 6. Others Features
Figure 7. Global Neuromodulators Injectable Market Share by Application: 2020 VS 2027
Figure 8. Hospitals Case Studies
Figure 9. Dermatology Clinics Case Studies
Figure 10. Spas and Aesthetic Clinics Case Studies
Figure 11. Neuromodulators Injectable Report Years Considered
Figure 12. Global Neuromodulators Injectable Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Neuromodulators Injectable Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Neuromodulators Injectable Market Share by Regions: 2020 VS 2027
Figure 15. Global Neuromodulators Injectable Market Share by Regions (2022-2027)
Figure 16. Global Neuromodulators Injectable Market Share by Players in 2020
Figure 17. Global Top Neuromodulators Injectable Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neuromodulators Injectable as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Neuromodulators Injectable Revenue in 2020
Figure 19. Global Neuromodulators Injectable Revenue Market Share by Type (2016-2021)
Figure 20. Global Neuromodulators Injectable Revenue Market Share by Type (2022-2027)
Figure 21. North America Neuromodulators Injectable Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Neuromodulators Injectable Market Share by Type (2016-2027)
Figure 23. North America Neuromodulators Injectable Market Share by Application (2016-2027)
Figure 24. North America Neuromodulators Injectable Market Share by Country (2016-2027)
Figure 25. United States Neuromodulators Injectable Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Neuromodulators Injectable Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Neuromodulators Injectable Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Neuromodulators Injectable Market Share by Type (2016-2027)
Figure 29. Europe Neuromodulators Injectable Market Share by Application (2016-2027)
Figure 30. Europe Neuromodulators Injectable Market Share by Country (2016-2027)
Figure 31. Germany Neuromodulators Injectable Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Neuromodulators Injectable Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Neuromodulators Injectable Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Neuromodulators Injectable Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Neuromodulators Injectable Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Neuromodulators Injectable Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Neuromodulators Injectable Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Neuromodulators Injectable Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Neuromodulators Injectable Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Neuromodulators Injectable Market Share by Region (2016-2027)
Figure 41. China Neuromodulators Injectable Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Neuromodulators Injectable Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Neuromodulators Injectable Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Neuromodulators Injectable Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Neuromodulators Injectable Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Neuromodulators Injectable Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Neuromodulators Injectable Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Neuromodulators Injectable Market Share by Type (2016-2027)
Figure 49. Latin America Neuromodulators Injectable Market Share by Application (2016-2027)
Figure 50. Latin America Neuromodulators Injectable Market Share by Country (2016-2027)
Figure 51. Mexico Neuromodulators Injectable Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Neuromodulators Injectable Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Neuromodulators Injectable Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Neuromodulators Injectable Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Neuromodulators Injectable Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Neuromodulators Injectable Market Share by Country (2016-2027)
Figure 57. Turkey Neuromodulators Injectable Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Neuromodulators Injectable Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Neuromodulators Injectable Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. ALLERGAN Revenue Growth Rate in Neuromodulators Injectable Business (2016-2021)
Figure 61. Merz Pharma Revenue Growth Rate in Neuromodulators Injectable Business (2016-2021)
Figure 62. Suneva Medical Revenue Growth Rate in Neuromodulators Injectable Business (2016-2021)
Figure 63. Medytox Revenue Growth Rate in Neuromodulators Injectable Business (2016-2021)
Figure 64. Sinclair Pharma Revenue Growth Rate in Neuromodulators Injectable Business (2016-2021)
Figure 65. Bloomage BioTechnology Corporation Limited Revenue Growth Rate in Neuromodulators Injectable Business (2016-2021)
Figure 66. Anika Therapeutics Revenue Growth Rate in Neuromodulators Injectable Business (2016-2021)
Figure 67. Galderma Revenue Growth Rate in Neuromodulators Injectable Business (2016-2021)
Figure 68. Bausch Health Companies Revenue Growth Rate in Neuromodulators Injectable Business (2016-2021)
Figure 69. Integra Lifesciences Revenue Growth Rate in Neuromodulators Injectable Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
世界の注射式しわ治療市場規模・現状・予測（2021年-2027年） Injectable anti –wrinkle are the treatment that are injected into the treatment area to reduce the skin lines and wrinkles. It can also fill the sagging skin and tighten the skin, reduce the frown lines, and lines under the eyes etc. The injectable anti-wrinkle treatment can help in rejuvenation of …- 乳酸及びポリ乳酸のグローバル市場調査 2019年 The global Lactic Acid & Poly Lactic Acid market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Lactic Acid & Poly Lactic Acid volume and value at global level, regional level and company level. From a gl…
- 世界の注射式標的治療市場規模・現状・予測（2021年-2027年） It is at the cellular and molecular level, designed for the treatment of well-defined carcinogenic sites, and designing corresponding therapeutic drugs. When drugs enter the body, they will specifically select carcinogenic sites to combine and act, causing tumor cells to die specifically, without Wi…
- 乳酸及びポリ乳酸（PLA）のグローバル市場調査 2019年 The global Lactic Acid & Poly Lactic Acid (PLA) market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Lactic Acid & Poly Lactic Acid (PLA) volume and value at global level, regional level and company leve…
- 世界の注射式鎮痛薬市場規模・現状・予測（2021年-2027年） Analgesics refer to drugs that can partially or completely relieve pain. There are two types of non-steroidal anti-inflammatory drugs and central analgesics. The latter is currently mainly used in the treatment of cancer pain, and can also be used for short-term postoperative pain relief. Market Ana…